Both treatment groups maintained good overall glycaemic control during the study (beginning and end of study HbA1c≤ 6%).
Both treatment groups maintained good overall glycaemic control during the study (beginning and end of the study HbA1cvalues ≤ 6%).
The body weight of patients who are treated by carbohydrate count method and multiple dosage intensive insulin treatment during the study beginning and after 6-month term, body mass index, and body compositions are analyzed.
Any and all adverse events (AEs) that occur during the course of the study, beginning from the time of randomization, are carefully documented.
Taking all deaths into consideration, the rate of death seemed to be constant during the course of the study, beginning about 7 weeks post-infection, confirming that C3HeB/FeJ mice are more susceptible to TB but, under the conditions studied, either progress at different rates or progress variably owing to early, stochastic events that set severe pathology in motion.
Assessment data were collected in 1 1.5 hour sessions during the week before the study began, after 4 weeks (immediately post-training), and after 3 and 6 months.
In addition, study results may be affected by the "drop in" phenomenon, where patients during the course of the study begin taking medications of a similar class or with an effect similar to that of the drug being evaluated in the study.
Demographic data including age, years of education, and mean self-reported total sleep time (TST, including daytime sleep and prophylactic sleep) for the night shift groups and the sleep time during the night before the study began for the OD group were recorded.
For the new study, which appears in the July issue of The Journal of Clinical Endocrinology and Metabolism, researchers at the University of São Paulo in Brazil recruited 36 healthy women, ages 20 to 35, who had not exercised regularly during the six months before the study began.
One week before the study began and during the course of the study, patients were asked not to take any analgesic or receive pain treatment.
Nineteen patients have died since the study began, all of whom were enrolled during the years 2003 2004.
